NCT06775821 is a clinical trial of Ultrasound or CT of the abdominal aorta in Abdominal Aortic Aneurysm, sponsored by First Affiliated Hospital of Kunming Medical University.

Who is sponsoring NCT06775821?

NCT06775821 is sponsored by First Affiliated Hospital of Kunming Medical University.

What drugs are being tested in NCT06775821?

Interventions in NCT06775821: Ultrasound or CT of the abdominal aorta.

What condition does NCT06775821 study?

NCT06775821 studies Abdominal Aortic Aneurysm, Primary Lung Cancer, Prevalence.

Is NCT06775821 still recruiting?

NCT06775821 is currently recruiting now. Last updated 15 January 2025.

Last reviewed 2025-01-15 · How we verify

NCT06775821

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Epidemiology of Abdominal Aortic Aneurysm With Concomitant Primary Lung Cancer

Recruiting now Last updated 15 January 2025

What this trial tests

trial testing Ultrasound or CT of the abdominal aorta in Abdominal Aortic Aneurysm in 2,000 participants. Currently enrolling.

Timeline

1 October 2022

Primary endpoint
30 April 2025

30 April 2025

Quick facts

Lead sponsor	First Affiliated Hospital of Kunming Medical University
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	2,000
Start date	1 October 2022
Primary completion	30 April 2025
Estimated completion	30 April 2025
Sites	2 locations across China

Drugs / interventions tested

Ultrasound or CT of the abdominal aorta

Conditions studied

Abdominal Aortic Aneurysm — all drugs for Abdominal Aortic Aneurysm →
Primary Lung Cancer — all drugs for Primary Lung Cancer →
Prevalence — all drugs for Prevalence →

Sponsor

First Affiliated Hospital of Kunming Medical University

Who can join

Adults 20 to 90, any sex, with Abdominal Aortic Aneurysm or Primary Lung Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Retrospective clinical case studies in recent years have shown that most cases of lung cancer and abdominal aortic aneurysm (AAA) are detected at the same time and that there is a wide variation in the prevalence of AAA in patients with primary lung cancer reported in the literature, with some papers suggesting as high as 11%, suggesting that there may be a relationship between the prevalence of the two diseases. However, its exact incidence and mechanism are unknown. Accurate prevention of AAA in patients with primary lung cancer requires more in-depth studies. To solve the above problems, a multi-center prospective epidemiological investigation and mechanism study on the association of AAA in primary lung cancer combined has become particularly urgent. The results of the study will be of great significance for the follow-up treatment and prognosis of lung cancer patients as well as the improvement of long-term survival rate of lung cancer patients, and will also provide scientific basis and clinical guidance for the screening and prevention of AAA in lung cancer patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Abdominal Aortic Aneurysm

Currently open trials in the same condition.

NCT07476196 — Poland-Italy Aortic Research Bridge Real World Registry · recruiting
NCT07473102 — PET Imaging of MMP Activation in AAA: Clinical Component · EARLY_PHASE1 · recruiting
NCT06451315 — REGISTRY on the Implementation of Artificial Intelligence in the Automatic Analysis of Vascular Network Segmentation · recruiting
NCT06001918 — Nectero EAST System Clinical Study · Phase 2, PHASE3 · recruiting
NCT06008613 — 3D Holographic Guidance, Navigation, and Control for Endovascular Aortic Repair · NA · active not recruiting

Other First Affiliated Hospital of Kunming Medical University trials

Trials by the same sponsor.

NCT07289178 — Effect of Liposome Bupivacaine Serratus Plane Block on Postoperative Hyperalgesia and Chronic Post-surgical Pain in Pati · Phase 1, PHASE2 · not yet recruiting
NCT07125573 — The Effect of Esketamine Combined With Dexmedetomidine on Postoperative Recovery Quality in Patients Undergoing Thoracos · NA · enrolling by invitation
NCT06028256 — Norepinephrine Prevent Post-induction Hypotension in High-risk Patients · Phase 4 · unknown
NCT07067541 — Clinical Observation of Topical Lidocaine Cream Combined With Moisturizing Cream in the Treatment of Atopic Dermatitis · NA · completed
NCT05741008 — Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal Carcinoma · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06775821 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by First Affiliated Hospital of Kunming Medical University
Last refreshed: 15 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06775821.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing